Elon Musk claims robots will outpace top surgeons in five years

Elon Musk recently predicted that robots will surpass top human surgeons within five years, citing Neuralink’s robotic precision in brain procedures. His statement stirred skepticism online, with users and medical professionals arguing that current surgical robots are merely tools guided by human hands, not autonomous systems.

In a recent post on X, Elon Musk claimed that robots will outperform skilled human surgeons within a few years, predicting that even the best surgeons would be outpaced by robotic precision in about five years. He highlighted Neuralink’s use of a robot for inserting brain-computer electrodes, noting that the required speed and accuracy exceeded human capabilities.

Musk’s prediction triggered widespread skepticism on social media. One user questioned the contradiction in Musk’s vision, asking, “How does it make sense to you to, on the one hand, push for a higher population, and on the other, plan to replace everyone’s jobs with robots? What are all these people going to do for work?” Another pointed out that current surgical robots are not autonomous but are controlled by humans. “Your comment makes it sound like current surgical robots can work autonomously, and that tweet is supporting that idea. It isn’t,” the user said. “Current fully autonomous robot surgeons = 0. So we’ve got to go from zero to ‘surpassing the best human surgeons’? No way. Eventually, you’ll be right, but this is just AI hype.”

A surgeon with experience in robot-assisted procedures added, “Misleading!! Robots are not actually doing the surgery; the surgeon is doing it with the console using the robot as a sophisticated tool. The surgeon makes every move, and the robot extends and refines that move. They are great tools, but not surgeons!”

Neuralink, valued at US$ 5 billion in 2023, is currently testing its brain implant on individuals with spinal cord injuries. The first patient used it to play video games, browse online, and move a cursor using only their brain. Although the US Food and Drug Administration initially rejected Neuralink’s clinical trial application, it later approved the trials, now in progress. Musk sees broader uses for the chip, including treating conditions like obesity, autism, and depression. Meanwhile, rival Synchron Inc. is also developing a similar implant for motor-impaired users.